Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

DSIP

Emideltide, DSIP nonapeptide, Delta sleep-inducing peptide

Quick Stats
Studies 458
Trials 82
Score 2
2009 pubmed

Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia.

Pomfrett. Chris J D CJ; Dolling. Stuart S; Anders. Nicola R K NR; Glover. David G DG; Bryan. Angella A; Pollard. Brian J BJ

Key Findings

  • DSIP increased heart rate and decreased heart‑rate variability, suggesting it reduces parasympathetic (rest‑and‑digest) activity.
  • During isoflurane anesthesia DSIP lowered delta EEG power, reduced burst‑suppression, and raised the BIS index, indicating a lighter depth of anesthesia.
  • DSIP changed the symmetry of EEG signals between the left and right hemispheres.

Practical Outcomes

  • For self‑experimenters, DSIP does not appear to act as a strong hypnotic or anesthetic enhancer; it may actually make you more alert and increase heart rate. Use caution if you plan to take DSIP for sleep or relaxation, as the dose used (25‑100 nmol/kg) showed these opposite effects. It’s not suitable as a substitute for conventional sedatives or as an anesthesia aid.

Summary

In a small study of 24 women undergoing surgery, giving the peptide Delta Sleep‑Inducing Peptide (DSIP) did not deepen the anesthetic state. Instead, it raised heart rate, lowered heart‑rate variability (a sign of reduced parasympathetic tone), cut the slow‑wave (delta) brain activity, and made the brain‑wave pattern look more like a lighter level of anesthesia.

Abstract

Delta sleep-inducing peptide (DSIP) is an endogenous peptide that crosses the blood-brain barrier, named after its association with natural sleep and enhanced electroencephalogram (EEG) delta rhythm. The objective of this study was to determine whether DSIP could be used as an adjunct to volatile anaesthesia in humans, our hypothesis being that DSIP is a natural hypnotic that would increase anaesthetic depth. The aims were to assess depth of anaesthesia using bispectral index (BIS), the EEG and heart rate variability (HRV), and to determine whether DSIP altered the symmetry of EEG between the left and right cerebral hemispheres. Twenty-four female ASA I or II patients gave written, informed consent to a protocol approved by our local research ethics committee. Twelve were randomly assigned as controls to receive saline. The other 12 were randomly allocated to receive one of three intravenous bolus doses of DSIP (Clinalfa) at 25, 50 or 100 nmol kg(-1). The first administration of DSIP was while awake and the second after induction of anaesthesia with propofol and maintenance with isoflurane. BIS and EEG parameters were measured continuously using a bilateral electrode montage. DSIP significantly increased heart rate, decreased HRV and, paradoxically, significantly reduced delta rhythm along with reducing burst suppression and increasing BIS at 25 nmol kg(-1) during isoflurane anaesthesia. DSIP also significantly altered bilateral symmetry of EEG. DSIP probably reduced parasympathetic tone and decreased (lightened) the depth of anaesthesia measured using BIS.

Study Information

Provider

pubmed

Year

2009

DOI

10.1097/eja.0b013e32831c8644